| Sep 6 |
Director MILNE GEORGE M JR Acquires 100,000 Shares of Amylyx Pharmaceuticals Inc (AMLX)
|
| Aug 28 |
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
|
| Aug 12 |
Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration
|
| Aug 10 |
We Think Amylyx Pharmaceuticals (NASDAQ:AMLX) Can Easily Afford To Drive Business Growth
|
| Aug 9 |
Amylyx Pharmaceuticals, Inc. (AMLX) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
Amylyx Pharmaceuticals GAAP EPS of -$1.07
|
| Aug 8 |
Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Madrigal (MDGL) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 5 |
Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
|
| Aug 5 |
EC grants orphan drug status for Amylyx’s Wolfram treatment
|
